Template:DrugProjectFormSinglePage: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
No edit summary
 
(6 intermediate revisions by 2 users not shown)
Line 82: Line 82:
{{PAGENAME}} is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. {{#if: {{{hasBlackBoxWarning|}}}| There is a Black Box Warning for this drug as shown {{BlackBoxHere}}.}}  Common adverse reactions include {{{adverseReactions}}}.
{{PAGENAME}} is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. {{#if: {{{hasBlackBoxWarning|}}}| There is a Black Box Warning for this drug as shown {{BlackBoxHere}}.}}  Common adverse reactions include {{{adverseReactions}}}.


{{#if: {{{fdaLIADAdult|}}} |
==Adult Indications and Dosage==
==Adult Indications and Dosage==


===FDA-Labeled Indications and Dosage (Adult)===
===FDA-Labeled Indications and Dosage (Adult)===
{{{fdaLIADAdult}}}
{{#if: {{{fdaLIADAdult|}}} |
{{{fdaLIADAdult|}}} |
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Adult)'' in the drug label.
}}
}}


Line 98: Line 99:
{{{offLabelAdultNoGuideSupport|}}}
{{{offLabelAdultNoGuideSupport|}}}
}}
}}
{{#if: {{{fdaLIADPed|}}} |


==Pediatric Indications and Dosage==
==Pediatric Indications and Dosage==


===FDA-Labeled Indications and Dosage (Pediatric)===
===FDA-Labeled Indications and Dosage (Pediatric)===
{{{fdaLIADPed|}}}
{{#if: {{{fdaLIADPed|}}} |
{{{fdaLIADPed|}}} |
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Pediatric)'' in the drug label.
}}
}}


Line 110: Line 111:
{{#if: {{{offLabelPedGuideSupport|}}} |
{{#if: {{{offLabelPedGuideSupport|}}} |
====Guideline-Supported Use====
====Guideline-Supported Use====
{{{offLabelPedGuideSupport|}}}
{{{offLabelPedGuideSupport|}}}
}}
}}
Line 119: Line 119:


==Contraindications==
==Contraindications==
{{{contraindications|}}}
{{#if: {{{contraindications|}}} |
{{{contraindications|}}} |
There is limited information regarding {{PAGENAME}} ''Contraindications'' in the drug label.
}}


==Warnings==
==Warnings==
Line 125: Line 128:
{{BlackBoxTemplate|blackBoxWarningTitle={{{blackBoxWarningTitle}}}|blackBoxWarningBody={{{blackBoxWarningBody}}}}}
{{BlackBoxTemplate|blackBoxWarningTitle={{{blackBoxWarningTitle}}}|blackBoxWarningBody={{{blackBoxWarningBody}}}}}
}}
}}
 
{{#if: {{{warnings|}}}|
{{{warnings|}}}
{{{warnings|}}} |
There is limited information regarding {{PAGENAME}} ''Warnings' in the drug label.
}}


==Adverse Reactions==
==Adverse Reactions==


===Clinical Trials Experience===
===Clinical Trials Experience===
{{{clinicalTrials|}}}
{{#if: {{{clinicalTrials|}}} |
{{{clinicalTrials|}}} |
There is limited information regarding {{PAGENAME}} ''Clinical Trials Experience'' in the drug label.
}}


===Postmarketing Experience===
===Postmarketing Experience===
{{{postmarketing|}}}
{{#if: {{{postmarketing|}}} |
{{{postmarketing|}}} |
There is limited information regarding {{PAGENAME}} ''Postmarketing Experience'' in the drug label.
}}


==Drug Interactions==
==Drug Interactions==
{{{drugInteractions|}}}
{{#if: {{{drugInteractions|}}} |
{{{drugInteractions|}}} |
There is limited information regarding {{PAGENAME}} ''Drug Interactions'' in the drug label.
}}


==Use in Specific Populations==
==Use in Specific Populations==
Line 143: Line 157:
====Pregnancy====
====Pregnancy====
'''[[Pregnancy category#United States|Pregnancy Category (FDA)]]: {{{FDAPregCat|}}}'''
'''[[Pregnancy category#United States|Pregnancy Category (FDA)]]: {{{FDAPregCat|}}}'''
{{#if: {{{useInPregnancyFDA|}}} |
{{#if: {{{useInPregnancyFDA|}}} |
{{{useInPregnancyFDA|}}} |
{{{useInPregnancyFDA|}}} |
There is no FDA guidance on usage of {{PAGENAME}} in women who are pregnant.
There is no FDA guidance on usage of {{PAGENAME}} in women who are pregnant.
}}
}}
 
<BR>
'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]: {{{AUSPregCat|}}}'''
'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]: {{{AUSPregCat|}}}'''
{{#if: {{{useInPregnancyAUS|}}} |
{{#if: {{{useInPregnancyAUS|}}} |
{{{useInPregnancyAUS|}}} |
{{{useInPregnancyAUS|}}} |
Line 187: Line 199:


====Race====
====Race====
{{#if: {{{useInRace|}}} |
{{#if: {{{useInRace|}}} |
{{{useInRace|}}} |
{{{useInRace|}}} |
Line 223: Line 234:


====Administration====
====Administration====
{{{administration|}}}
{{#if: {{{administration|}}} |
{{{administration|}}} |
There is limited information regarding {{PAGENAME}} ''Administration'' in the drug label.
}}


====Monitoring====
====Monitoring====
{{{monitoring|}}}
{{#if: {{{monitoring|}}} |
{{{monitoring|}}} |
There is limited information regarding {{PAGENAME}} ''Monitoring'' in the drug label.
}}


==IV Compatibility==
==IV Compatibility==
Line 237: Line 254:
{{#if: {{{overdose|}}} |
{{#if: {{{overdose|}}} |
{{{overdose|}}} |
{{{overdose|}}} |
There is limited information regarding {{PAGENAME}} overdose.  If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
There is limited information regarding {{PAGENAME}} overdosage.  If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
}}
}}


==Pharmacology==
==Pharmacology==
{{{drugBox|}}}
{{#if: {{{drugBox|}}} |
{{{drugBox|}}} |
There is limited information regarding {{PAGENAME}} ''Pharmacology'' in the drug label.
}}


===Mechanism of Action===
===Mechanism of Action===
{{{mechAction|}}}
{{#if: {{{mechAction|}}} |
{{{mechAction|}}} |
There is limited information regarding {{PAGENAME}} ''Mechanism of Action'' in the drug label.
}}


===Structure===
===Structure===
{{{structure|}}}
{{#if: {{{structure|}}} |
{{{structure|}}} |
There is limited information regarding {{PAGENAME}} ''Structure'' in the drug label.
}}


===Pharmacodynamics===
===Pharmacodynamics===
{{{PD|}}}
{{#if: {{{PD|}}} |
{{{PD|}}} |
There is limited information regarding {{PAGENAME}} ''Pharmacodynamics'' in the drug label.
}}


===Pharmacokinetics===
===Pharmacokinetics===
{{{PK|}}}
{{#if: {{{PK|}}} |
{{{PK|}}} |
There is limited information regarding {{PAGENAME}} ''Pharmacokinetics'' in the drug label.
}}


===Nonclinical Toxicology===
===Nonclinical Toxicology===
{{{nonClinToxic|}}}
{{#if: {{{nonClinToxic|}}} |
{{{nonClinToxic|}}} |
There is limited information regarding {{PAGENAME}} ''Nonclinical Toxicology'' in the drug label.
}}


==Clinical Studies==
==Clinical Studies==
{{{clinicalStudies|}}}
{{#if: {{{clinicalStudies|}}} |
{{{clinicalStudies|}}} |
There is limited information regarding {{PAGENAME}} ''Clinical Studies'' in the drug label.
}}


==How Supplied==
==How Supplied==
{{{howSupplied|}}}
{{#if: {{{howSupplied|}}} |
{{{howSupplied|}}} |
There is limited information regarding {{PAGENAME}} ''How Supplied'' in the drug label.
}}


===Storage===
===Storage===
{{{storage|}}}
{{#if: {{{storage|}}} |
{{{storage|}}} |
There is limited information regarding {{PAGENAME}} ''Storage'' in the drug label.
}}


==Images==
==Images==
===Drug Images===
===Drug Images===
{{{drugImages|}}}
{{{drugImages|}}}
{{#ask: [[Page Name::{{PAGENAME}}]]
{{#ask: [[Page Name::{{PAGENAME}}]]
|?Pill Name
|?Pill Name
Line 290: Line 333:
===Package and Label Display Panel===
===Package and Label Display Panel===
{{{packLabel|}}}
{{{packLabel|}}}
{{#ask: [[Label Page::{{PAGENAME}}]]
{{#ask: [[Label Page::{{PAGENAME}}]]
|?Label Name
|?Label Name
Line 298: Line 340:
|sort=Label Page
|sort=Label Page
}}
}}
==Patient Counseling Information==
==Patient Counseling Information==
{{{fdaPatientInfo|}}}
{{#if: {{{fdaPatientInfo|}}} |
{{{fdaPatientInfo|}}} |
There is limited information regarding {{PAGENAME}} ''Patient Counseling Information'' in the drug label.
}}


==Precautions with Alcohol==
==Precautions with Alcohol==
Line 309: Line 353:


==Brand Names==
==Brand Names==
{{{brandNames|}}}
{{#if: {{{brandNames|}}} |
{{{brandNames|}}} |
There is limited information regarding {{PAGENAME}} ''Brand Names'' in the drug label.
}}


==Look-Alike Drug Names==
==Look-Alike Drug Names==
{{{lookAlike|}}}
{{#if: {{{lookAlike|}}} |
{{{lookAlike|}}} |
There is limited information regarding {{PAGENAME}} ''Look-Alike Drug Names'' in the drug label.
}}


==[http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm Drug Shortage Status]==
==[http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm Drug Shortage Status]==
Line 322: Line 372:
==References==
==References==
The contents of this FDA label are provided by the National Library of Medicine.
The contents of this FDA label are provided by the National Library of Medicine.
{{reflist|2}}
{{reflist|2}}


</div>
</div>
</includeonly>
</includeonly>

Latest revision as of 17:13, 1 August 2017

This is the "Drug Project Form" template. It should be called in the following format:

{{DrugProjectForm
|authorTag=
|genericName=
|drugClass=
|indication=
|indicationType=
|commonAdverseReactions=
|hasBlackBoxWarning=
|blackBoxWarningTitle=
|blackBoxWarningBody=
|fdaLIADAdult=
|offLabelAdultGuideSupport=
|offLabelAdultNoGuideSupport=
|fdaLIADPed=
|offLabelPedGuideSupport=
|offLabelPedNoGuideSupport=
|contraindications=
|warnings=
|adverseReactions=
|clinicalTrials=
|postmarketing=
|drugInteractions=
|FDAPregCat=
|useInPregnancyFDA=
|AUSPregCat=
|useInPregnancyAUS=
|useInLaborDelivery=
|useInNursing=
|useInPed=
|useInGeri=
|useInGender=
|useInRace=
|useInRenalImpair=
|useInHepaticImpair=
|useInReproPotential=
|useInImmunocomp=
|othersTitle=
|useInOthers=
|administration=
|monitoring=
|IVCompat=
|overdose=
|drugBox=
|mechAction=
|structure=
|PD=
|PK=
|nonClinToxic=
|clinicalStudies=
|howSupplied=
|NDC=
|storage= 
|manBy=  
|distBy=
|drugImages=
|packLabel=
|fdaPatientInfo=
|nlmPatientInfo=
|alcohol=
|brandNames=
|lookAlike=
|drugShortage=
|price=
}}

Edit the page to see the template text.